Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex

Yu Yi Chu, Mei Kuang Chen, Yongkun Wei, Heng Huan Lee, Weiya Xia, Ying Nai Wang, Clinton Yam, Jennifer L. Hsu, Hung Ling Wang, Wei Chao Chang, Hirohito Yamaguchi, Zhou Jiang, Chunxiao Liu, Ching Fei Li, Lei Nie, Li Chuan Chan, Yuan Gao, Shao Chun Wang, Jinsong Liu, Shannon N. WestinSanghoon Lee, Anil K. Sood, Liuqing Yang, Gabriel N. Hortobagyi, Dihua Yu, Mien Chie Hung

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting the ALK–CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex'. Together they form a unique fingerprint.

Medicine & Life Sciences